You are currently visiting the Safic-Alcan France website.
Lynside S.Boulardii PW 20
Provided by Gnosis By Lesaffre
About
Lynside® Pro SCB is a proprietary, patented probiotic yeast strain used in nutraceutical applications, developed by Lesaffre for digestive and immune health support, including compatibility with antibiotic therapy.
Key Benefits:
• Registered strain Saccharomyces cerevisiae var. boulardii CNCM I-3799, backed by an extensive clinical research programme spanning several decades
• Positioned for digestive health support: acute diarrhea in children, occasional traveler’s diarrhea, and gut microbiota support during antibiotic-associated digestive disruption
• Eukaryotic yeast structure: naturally unaffected by antibiotic treatment, allowing simultaneous intake without loss of efficacy
• Naturally resistant to gastric acid and bile salts, no protective encapsulation required
• No colonization effect: transient action, cleared from the gastrointestinal tract within 3 to 5 days after discontinuation, preserving the native gut microbiota balance
• US GRAS and EU QPS status, non-GMO, gluten-free, lactose-free, suitable for Kosher, Halal, vegetarian and vegan diets
• Superior stability: 3 to 5 years at ambient temperature, available in rod-shape (vermicelli) and powder formats
• Recommended dosage: approximately 5 billion CFU/day (200 to 250 mg)
• Produced by Gnosis by Lesaffre and distributed by Safic-Alcan
Typical Applications:
Saccharomyces boulardii / probiotic yeast for antibiotic-compatible formulations, digestive health, travel wellness, and immune support product lines. Suitable for capsules and sachets. Complementary ingredient for gut-health and immune-support ranges, including combination formulas with prebiotic yeast fractions or bacterial probiotic strains.
| Benefits |
|
|---|---|
| Applications |
|
| Grade Name | Lynside S.Boulardii PW 20 |
| Category |
|
About gnosis by lesaffre
For over 30 years, Lesaffre has been involved in Human Health & Nutrition as part of its ambition to Better Nourish and Protect the Planet. In November 2018, Lesaffre acquired Gnosis Advanced Biotech and officially combined it with Lesaffre Human Care to form a new Business Unit named Gnosis by Lesaffre. At Gnosis by Lesaffre, we are committed to cultivating and to delivering nutritional actives, probiotics, and nutritional and functional yeasts that benefit human health and wellbeing, thanks to the power of microorganisms and biotransformation processes like fermentation. Put differently, we explore life to improve living. Our vision: At Gnosis by Lesaffre, we strive for a world that moves better, digests better, ages better, feels better, and, ultimately, lives better thanks to microorganisms and biotransformation.
